[1]
|
B. V. Maramattom, C. Giannini, E. M. Manno and E. F. Wijdicks, “Wegener’s,” 2005.
http://www.ncibi.nlm.nih.gov/pubmed/15980626granulo-matosis
http://www.ncibi.nlm.nih.gov/pubmed/15980626
|
[2]
|
H. A. Rula, R. Silverstein, G. Hoffman, L. Zhang, P. Imrey and C. Langford, “The Correlation between Circulating Microparticles and Platelet Aggregation and Disease Activity in Wegener Granulomatosis,” Arthritis and Rheumatism, Vol. 62, Supplement 10, 2010, p. S856.
|
[3]
|
M. DeBandt, V. Ollivier, O. Meyer, C. Babin-Chevaye, F. Khechai, D. de Prost, J. Hakim and C. Pasquier, “Induction of Interleukin-1 and Subsequent Tissue Factor Expression by Anti-Proteinase 3 Antibodies in Human Umbilical Vein Endothelial Cells,” Arthritis Rheum, Vol. 40, No. 11, 1997, pp. 2030-2038.
doi:10.1002/art.1780401116
|
[4]
|
P. A. Merkel, G. H. Lo, J. T. Holbrook, et al., “Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener’s Clinical Occurrence of Thrombosis (WeCLOT) Study,” Annals of Internal Medicine, Vol. 142, No. 8, 2005, pp. 620-626.
|
[5]
|
G. S. Hoffman, G. S. Kerr, R. Y. Leavitt, C. W. Hallahan, R. S. Lebovics, W. D. Travis, et al., “Wegener Granulomatosis: An Analysis of 158 Patients,” Annals of Internal Medicine, Vol. 116, No. 6, 1992, pp. 488-498
|
[6]
|
R. Seror, A. Mahr, J. Ramanoelina, C. Pagnoux, P. Cohen and L. Guillevin, “Central Nervous System Involvement in Wegener’s Granulomatosis,” Medicine, Vol. 85, No. 1, 2006, pp. 54-65.
|
[7]
|
H. Nishino, F. A. Rubino and J. E. Parisi, “The Spectrum of Neurologic Involvement in Wegener’s Granuloma- tosis,” Neurology, Vol. 43, No. 7, 1993, pp. 1334-1337.
|
[8]
|
W. Zhang, G. Zhou, Q. Shi, X. Zhang, X. F. Zeng and F. C. Zhang, “Clinical Analysis of Nervous System Involvement in ANCA-Associated Systemic Vasculitides,” Clinical and Experimental Rheumatology, Vol. 27, Supplement 52, 2009, pp. S65-S69.
|
[9]
|
J. U. Holle and W. L Gross, “Neurological Involvement in Wegener’s Granulomatosis,” Current Opinion Rheu- matology, Vol. 23, No. 1, 2011, pp. 7-11.
doi:10.1097/BOR.0b013e32834115f9
|
[10]
|
J. M. Provenzale and N. B. Allen, “Wegener Granulomatosis: CT and MR Findings,” American Journal of Neuroradiology, Vol. 17, 1996, pp. 785-792.
|
[11]
|
B. A. Cunha, “Nervous System Infections in the Com- promised Host: A Diagnostic Approach,” Infectious Di- sease Clinics of North America Central, Vol. 15, No. 1, 2001, pp. 567-590.
|
[12]
|
J. U. Holle, W. L. Gross, U. Latza, B. Noelle, P. Ambrosch, M. Heller, R. Fertmann and E. Reinhold-Keller, “Improved Outcome of 445 Wegener’s Granulomatosis Patients in a German Vasculitis Center over Four Decades,” Arthritis & Rheumatism, Vol. 63, No. 1, 2010, pp. 257-266.
|
[13]
|
R. Luqmani, R. Suppiah, C. J. Edwards, R. Phillip, J. Maskell, D. Culliford, D. Jayne, K. Morishita and N. Arden, “Mortality in Wegener’s Granulomatosis: A Bimodal Pattern,” Rheumatology, Vol. 50, No. 4, 2010, pp. 597-702.
|
[14]
|
G. S. Hoffman, Y. Drucker, M. F. Cotch, et al., “Wege- ner’s Granulomatosis: Patient-Reported Effects of Disease on Health, Function, and Income,” Arthritis & Rheumatism, Vol. 41, No. 12, 1998, pp. 2257-2262.
doi:10.1002/1529-0131(199812)41:12<2257::AID-ART22>3.0.CO;2-K
|
[15]
|
E. Reinhold-Keller, N. Beuge, U. Latza, et al., “An Inter- disciplinary Approach to the Care of Patients with Wegener’s Granulomatosis: Long-Term Outcome in 155 Patients,” Arthritis & Rheumatism, Vol. 43, No. 5, 2000, pp. 1021-1032.
doi:10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J
|
[16]
|
K. De Groot, L. Harper, D. R. Jayne, L. F. Flores Suarez, G. Gregorinin, W. L. Gross, et al., “Pulse versus Daily Oral Cyclophopshamide for Induction of Remission in Antineu-Trophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial,” Annals of Internal Medi- cine, Vol. 150, 2009, pp. 670-680.
|
[17]
|
A. D. Booth, M. K. Almond, A. Burns, et al., “Pan- Thames Renal Research Group. Outcome of ANCA- Associated Renal Vasculitis: A Five-Year Retrospective Study,” American Journal of Kidney Diseases, Vol. 41, No. 4, 2003, pp. 776-784.
doi:10.1016/S0272-6386(03)00025-8
|
[18]
|
C. Charlier, C. Henegar, O. Launay, C. Pagnoux, A. Berezné, B. Bienvenu, P. Cohen, L. Mouthon and L. Guillevin, “Risk Factors for Major Infections in Wegener Granulomatosis: Analysis of 113 Patients,” Annals of the Rheumatic Disease, Vol. 68, No. 5, 2009, pp. 658-663.
doi:10.1136/ard.2008.088302
|
[19]
|
M. Little, P. Nightingale, C. A. Verburgh, et al., “Early Mortality in Systemic Vasculitis: Relative Contribution of Adverse Events and Active Vasculitis,” Annals of the Rheumatic Disease, Vol. 69, No. 6, 2010, pp. 1036-1043.
doi:10.1136/ard.2009.109389
|
[20]
|
A. Ibrahim, B. Spellberg and J. Edwards, “Iron Acqui- sition: A Novel Prospective on Mucormycosis Patho- genesis and Treatment,” Current Opinion in Infectious Disease, Vol. 21, No. 6, 2008, pp. 620-625.
doi:10.1097/QCO.0b013e3283165fd1
|
[21]
|
W.-F. Li, H. E. Chao, X.-F. Liu, S.-Y. Wang, J.-L. Qu and Z.-F. Lin, “A Diagnosis Neglected for 6 Years: Report of a Misdiagnosed Case of Pulmonary Mucor- mycosis and Review of the Literature,” Chinese Medical Journal, Vol. 123, No. 17, 2010, pp. 2480-2482
|
[22]
|
M. F. Liu, F. F. Chen, T. R. Hsiue and C. C. Liu, “Disseminated Zygomycosis Simulating Cerebrovascular Disease and Pulmonary Alveolar Haemorrhage in a Pa- tient with Systemic Lupus Erythematosus,” Clinical Rheu- matology, Vol. 19, No. 4, 2000, pp. 311-314.
doi:10.1007/s100670070052
|
[23]
|
E. Nogueira, P. W. Ind, J. Friedland and A. D. Salama, “Mucormycosis May Mimic Disease Relapse in Wege- ner’s Granulomatosis,” The Journal of Rheumatology, Vol. 37, No. 6, 2010, pp. 1364-1365.
doi:10.3899/jrheum.091423
|
[24]
|
J. D. Finkielman, P. A. Merkel, D. Schroeder, et al., “Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis,” Annals of Internal Medicine, Vol. 147, No. 9, 2007, pp. 611-619.
|
[25]
|
R. J. Falk and G. S. Hoffman, “Controversies in Small Vessel Vasculitis,” Current Opinion in Rheumatology, Vol. 19, No. 1, 2007, pp. 1-9.
|
[26]
|
H. P. McAdams, M. R. de Christenson, D. C. Strollo and E. F. Patz Jr., “Pulmonary Mucormycosis: Radiologic Findings in 32 Cases,” American Journal of Neurora- diology, Vol. 168, No. 6, 1997, pp. 1541-1548.
|
[27]
|
J. H. Stone, P. A. Merkel, R. Spiera, P. Seo, C. A. Langford, G. S. Hoffman, U. Specks, et al., “RAVE-ITN Research Group,” The New England Journal of Medicine, Vol. 5, No. 363, 2010, pp. 221-232.
doi:10.1056/NEJMoa0909905
|